{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:27:44Z","timestamp":1768710464186,"version":"3.49.0"},"reference-count":107,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["2R01HL136211-6A1"],"award-info":[{"award-number":["2R01HL136211-6A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Disseminated disease following invasive pulmonary aspergillosis (IPA) remains a significant contributor to mortality amongst patients with hematologic malignancies (HMs). At the highest risk of mortality are those with disseminated disease to the central nervous system, known as cerebral aspergillosis (CA). However, little is known about the risk factors contributing to disease amongst HM patients. A systematic review using PRISMA guidelines was undertaken to define HM patient subgroups, preventative measures, therapeutic interventions, and outcomes of patients with disseminated CA following IPA. The review resulted in the identification of 761 records, of which 596 articles were screened, with the final inclusion of 47 studies and 76 total patients. From included articles, the proportion of CA was assessed amongst HM patient subgroups. Further, pre-and post-infection characteristics, fungal species, and mortality were evaluated for the total population included and HM patient subgroups. Patients with acute myeloid leukemia and acute lymphoid lymphoma, patients receiving corticosteroids as a part of their HM therapeutic regimen, and anti-fungal prophylaxis constitute the top identified patient populations at risk for disseminated CA. Overall, information presented here indicates that measures for the prevention of IPA should be taken in higher-risk HM patient subgroups. Specifically, the type of anti-fungal therapy used should be carefully considered for those patients with IPA and increased risk for cerebral dissemination. Additional reports detailing patient characteristics are needed to define further the risk of developing disseminated CA from IPA in patients with HMs.<\/jats:p>","DOI":"10.3390\/jof8070722","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T21:57:53Z","timestamp":1657576673000},"page":"722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-5118","authenticated-orcid":false,"given":"Brianne N.","family":"Sullivan","sequence":"first","affiliation":[{"name":"Tulane Brain Institute, School of Science and Engineering, Tulane University, New Orleans, LA 70112, USA"},{"name":"Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia A.","family":"Baggett","sequence":"additional","affiliation":[{"name":"Tulane Brain Institute, School of Science and Engineering, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha S.","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Office of Academic Affairs and Provost, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-5410","authenticated-orcid":false,"given":"Keith M.","family":"Pickett","sequence":"additional","affiliation":[{"name":"Rudolph Matas Library of the Health Sciences, School of Medicine, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Steele","sequence":"additional","affiliation":[{"name":"Tulane Brain Institute, School of Science and Engineering, Tulane University, New Orleans, LA 70112, USA"},{"name":"Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/hupa.2002.30186","article-title":"Central nervous system aspergillosis: A 20-year retrospective series","volume":"33","year":"2002","journal-title":"Hum. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15761\/PCCM.1000114","article-title":"The Changing Epidemiology of Invasive Aspergillosis in the Non-Traditional Host: Risk Factors and Outcomes","volume":"1","author":"Vazquez","year":"2016","journal-title":"Pulm. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1590\/S1413-86702008000500008","article-title":"Invasive Aspergillosis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Analysis","volume":"12","author":"Sola","year":"2008","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"Segal","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-802395-2.00018-3","article-title":"Parasitic and fungal infections","volume":"145","author":"Deigendesch","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Henao-Mart\u00ednez, A.F., and Vela-Duarte, D. (2018). Chapter 13\u2014Cryptococcal Meningitis and Other Opportunistic Fungal Infections of the Central Nervous System: Epidemiology, Pathogenesis, Diagnosis, and Treatment, Elsevier Inc.","DOI":"10.1016\/B978-0-12-813806-9.00013-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jon199443123","article-title":"Central Nervous System Aspergillosis: Analysis of 26 Patients","volume":"4","author":"Boes","year":"1994","journal-title":"J. Neuroimaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jinf.2017.09.011","article-title":"Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000\u20132016): Uncommon, with improved survival but still deadly often","volume":"75","author":"Economides","year":"2017","journal-title":"J. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.idc.2015.10.015","article-title":"Invasive Aspergillosis: Current Strategies for Diagnosis and Management","volume":"30","author":"Cadena","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis Case-Fatality Rate: Systematic Review of the Literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/clinids\/23.3.628","article-title":"Localization of aspergillosis to the central nervous system among patients with acute leukemia: Report of 14 cases. Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Infection Program","volume":"23","author":"Pagano","year":"1996","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: A series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine"},{"key":"ref_15","first-page":"1","article-title":"A 10-year study reveals clinical and laboratory evidence for the \u2018semi-invasive\u2019 properties of chronic pulmonary aspergillosis","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J. Fungi., 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/jhin.2001.1170","article-title":"Clinical significance of extra-pulmonary involvement of invasive aspergillosis: A retrospective autopsy-based study of 107 patients","volume":"50","author":"Hori","year":"2002","journal-title":"J. Hosp. Infect."},{"key":"ref_18","first-page":"528","article-title":"Invasive pulmonary aspergillosis in patients with hematologic malignancies: Survival and prognostic factors","volume":"87","author":"Subira","year":"2002","journal-title":"Haematologica"},{"key":"ref_19","first-page":"337","article-title":"Angio-invasive disseminated aspergillosis: Autopsy diagnosis in leukemic patients","volume":"10","year":"1993","journal-title":"An. Med. Interna"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5589-5589","DOI":"10.1182\/blood.V122.21.5589.5589","article-title":"Autopsy Analysis On Epidemiology and Site of Involvement Of Invasive Fungal Infections (IFI) In Hematological Malignancies: A Retrospective Study at Hematologic Tertiary Care Department","volume":"122","author":"Chierichini","year":"2013","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2169\/internalmedicine.1226-18","article-title":"An autopsy case with cerebral hemorrhaging due to disseminated aspergillosis during glucocorticoid therapy for overlap syndrome of systemic lupus erythematosus and systemic sclerosis","volume":"58","author":"Ueno","year":"2019","journal-title":"Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00005792-200007000-00008","article-title":"Central nervous system aspergillosis in patients with human immunodeficiency virus infection: Report of 6 cases and review","volume":"79","author":"Mylonakis","year":"2000","journal-title":"Medicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijid.2007.01.013","article-title":"Central nervous system aspergillosis in children: A systematic review of reported cases","volume":"11","author":"Dotis","year":"2007","journal-title":"Int. J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bmt.1703812","article-title":"Central nervous system aspergillosis in allogeneic stem cell transplant recipients","volume":"31","author":"Jantunen","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1080\/13693780802537953","article-title":"Cerebral aspergillosis: Tissue penetration is the key","volume":"47","author":"Schwartz","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00207454.2016.1155573","article-title":"Cerebral aspergillosis: A retrospective analysis of eight cases","volume":"127","author":"Wang","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.56.2.188","article-title":"CNS aspergillosis in organ transplantation: A clinicopathological study","volume":"56","author":"Lopez","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Amanati, A., Lotfi, M., Masoudi, M.S., Jafarian, H., Ghasemi, F., Bozorgi, H., and Badiee, P. (2020). Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: Case report study. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05162-9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410180511","article-title":"Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients","volume":"18","author":"Walsh","year":"1985","journal-title":"Ann. Neurol."},{"key":"ref_30","unstructured":"Sullivan, B.N.B.M., O\u2019Connell, S.S., Pickett, K.M., and Steele, C. (2021, December 02). A Systematic Review and Meta-Analysis to Assess the Relationship between Disseminated Cerebral Aspergillosis and Therapeutics used in Leukemias and Lymphomas. Available online: https:\/\/www.crd.york.ac.uk\/PROSPERO\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid. Based Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.medmal.2018.01.003","article-title":"Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?","volume":"48","author":"Gaye","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1439-0507.1999.00496.x","article-title":"Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival","volume":"42","author":"Groll","year":"1999","journal-title":"Mycoses"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.031","article-title":"Acute Stroke as First Manifestation of Cerebral Aspergillosis","volume":"27","author":"Anciones","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1128\/JCM.00466-06","article-title":"Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay","volume":"44","author":"Hummel","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/646698","article-title":"Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants","volume":"14","author":"Iwen","year":"1993","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/513662","article-title":"Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature","volume":"24","author":"Iwen","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s002470000271","article-title":"Imaging aspects of neurologic emergencies in children treated for non-CNS malignancies","volume":"30","author":"Kaste","year":"2000","journal-title":"Pediatr. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2169\/internalmedicine.41.1130","article-title":"Cerebrovascular disease in acute leukemia: A clinicopathological study of 14 patients","volume":"41","author":"Kawanami","year":"2002","journal-title":"Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1439-0507.1991.tb00800.x","article-title":"Therapy of invasive aspergillosis with itraconazole: Improvement of therapeutic efficacy by early diagnosis","volume":"34","author":"Kreisel","year":"1991","journal-title":"Mycoses"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_43","first-page":"374","article-title":"Improved survival in central nervous system aspergillosis: A series of immunocompromised children with leukemia undergoing stereotactic resection of aspergillomas\u2014Report of four cases","volume":"103","author":"Middelhof","year":"2005","journal-title":"J. Neurosurg."},{"key":"ref_44","first-page":"140-140","article-title":"Invasive aspergillosis during consolidation chemotherapy for acute myeloid leukemia: Report of two simultaneous cases involving central nervous system","volume":"100","author":"Pascale","year":"2015","journal-title":"Haematologica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/myc.13001","article-title":"Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study","volume":"62","author":"Ruchlemer","year":"2019","journal-title":"Mycoses"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jgar.2020.03.016","article-title":"Management of cerebral azole-resistant Aspergillus fumigatus infection: A role for intraventricular liposomal-amphotericin B","volume":"22","author":"Schauwvlieghe","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00172950","article-title":"Cerebral infection complicating systemic aspergillosis in acute-leukemia\u2014Clinical and radiographic presentation","volume":"13","author":"Sparano","year":"1992","journal-title":"J. Neuro-Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"Snelders","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00043426-200304000-00004","article-title":"Prolonged survival after invasive aspergillosis: A single-institution review of 11 cases","volume":"25","author":"Wright","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1179\/146532807X192516","article-title":"Invasive fungal infection in children undergoing chemotherapy for cancer","volume":"27","author":"Yeh","year":"2007","journal-title":"Ann. Trop. Paediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/pbc.21601","article-title":"Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia","volume":"51","author":"Zwitserloot","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2257.2006.00737.x","article-title":"Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole","volume":"28","author":"Wandroo","year":"2006","journal-title":"Clin. Lab. Haematol."},{"key":"ref_53","first-page":"493","article-title":"Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT","volume":"11","author":"Trigg","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ajcp\/80.5.728","article-title":"Disseminated infection by Aspergillus terreus","volume":"80","author":"Tracy","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1469-0691.2004.00981.x","article-title":"Successful treatment of brain aspergillosis with voriconazole","volume":"10","author":"Tattevin","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000496555","article-title":"The Muddied Waters of Ibrutinib Therapy","volume":"141","author":"Pravda","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_57","first-page":"701","article-title":"Unusual invasive bronchial aspergillosis in a patient with acute lymphoblastic leukemia","volume":"82","author":"Sancho","year":"1997","journal-title":"Haematologica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12185-020-02980-0","article-title":"Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation","volume":"113","author":"Sakata","year":"2021","journal-title":"Int. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0971-5851.107104","article-title":"Cerebral aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy","volume":"33","author":"Prakash","year":"2012","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_60","first-page":"119","article-title":"Aspergillosis of the central nervous system: A catastrophic opportunistic infection","volume":"35","author":"Pongbhaesaj","year":"2004","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/00365548.2014.968611","article-title":"Dramatic response to itraconazole in central nervous system aspergillosis complicating acute promyelocytic leukemia","volume":"47","author":"Peng","year":"2015","journal-title":"Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00004728-198406000-00009","article-title":"Computed tomography of neuraxis aspergillosis","volume":"8","author":"Nov","year":"1984","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02681219880000171","article-title":"Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus flavus","volume":"36","author":"Mori","year":"1998","journal-title":"Med. Mycol."},{"key":"ref_64","first-page":"Ecr05","article-title":"Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient","volume":"88","author":"Marbello","year":"2003","journal-title":"Haematologica"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10428199709068287","article-title":"Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia","volume":"27","author":"Mahlknecht","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jpedsurg.2005.03.104","article-title":"Case report: Successful interdisciplinary treatment of cerebrally disseminated invasive pulmonal aspergillosis in a child with acute myeloid leukemia","volume":"40","author":"Kurdow","year":"2005","journal-title":"J. Pediatr. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3947\/ic.2012.44.5.395","article-title":"Disseminated invasive aspergillosis with multiple brain abscess after allogeneic hematopoietic stem cell transplantation treated successfully with voriconazole and neurosurgical intervention","volume":"44","author":"Im","year":"2012","journal-title":"Infect. Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00441214","article-title":"Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child","volume":"138","author":"Henze","year":"1982","journal-title":"Eur. J. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s003300100957","article-title":"Cerebral and spinal cord involvement resulting from invasive aspergillosis","volume":"12","author":"Guermazi","year":"2002","journal-title":"Eur. Radiol."},{"key":"ref_70","first-page":"396395","article-title":"Successful treatment of fanconi anemia and T-cell acute lymphoblastic leukemia","volume":"2012","author":"Flatt","year":"2012","journal-title":"Case Rep. Hematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1177\/1078155218788717","article-title":"Cerebral aspergillosis in a patient on ibrutinib therapy\u2014A predisposition not to overlook","volume":"25","author":"Faisal","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mmcr.2019.12.007","article-title":"A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy","volume":"27","author":"Eichenberger","year":"2020","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1097\/MPH.0000000000001508","article-title":"Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature","volume":"42","author":"Novielli","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00277-003-0792-0","article-title":"Rapid improvement of disseminated aspergillosis with caspofungin\/voriconazole combination in an adult leukemic patient","volume":"83","author":"Damaj","year":"2004","journal-title":"Ann. Hematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mmcr.2019.02.005","article-title":"Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia","volume":"24","author":"Beresford","year":"2019","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/pbc.20515","article-title":"Treatment of disseminated aspergillosis with voriconazole\/liposomal amphotericin B in a child with leukemia","volume":"45","author":"Athanassiadou","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1179\/1973947815Y.0000000009","article-title":"Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl","volume":"29","author":"Palmisani","year":"2017","journal-title":"J. Chemother."},{"key":"ref_78","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: Incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2011","journal-title":"Haematologica"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00134-019-05789-6","article-title":"Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies","volume":"45","author":"Pardo","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cix297","article-title":"Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999\u20132015","volume":"65","author":"Heo","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10552-016-0780-z","article-title":"Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)","volume":"27","author":"Li","year":"2016","journal-title":"Cancer Causes Control"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","article-title":"Invasive Fungal Disease in Adults Undergoing Remission-Induction Therapy for Acute Myeloid Leukemia: The Pathogenetic Role of the Antileukemic Regimen","volume":"21","author":"Bow","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.9778\/cmajo.20130062","article-title":"Incidence of invasive aspergillosis following remission\u2013induction chemotherapy for acute leukemia: A retrospective cohort study in a single Canadian tertiary care centre","volume":"2","author":"Barkati","year":"2014","journal-title":"CMAJ Open"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e00355-18","DOI":"10.1128\/AAC.00355-18","article-title":"Primary Fungal Prophylaxis in Hematological Malignancy: A Network Meta-Analysis of Randomized Controlled Trials","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e2018063","DOI":"10.4084\/mjhid.2018.063","article-title":"Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs","volume":"10","author":"Facchinelli","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1080\/10428194.2018.1543884","article-title":"High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia","volume":"60","author":"Teh","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMc1600328","article-title":"Ibrutinib for Chronic Lymphocytic Leukemia","volume":"374","author":"Sharman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41016-020-00187-0","article-title":"Invasive sphenoid sinus aspergillosis mimicking sellar tumor: A report of 4 cases and systematic literature review","volume":"6","author":"Zhang","year":"2020","journal-title":"Chin. Neurosurg. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1025-1025","DOI":"10.1111\/bjh.17354","article-title":"Cerebral aspergillosis in a patient on ibrutinib therapy","volume":"193","author":"Creuzet","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/10428194.2018.1485913","article-title":"Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib","volume":"60","author":"Cummins","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"783-783","DOI":"10.1182\/blood.V128.22.783.783","article-title":"Single-Agent Ibrutinib in Recurrent\/Refractory Central Nervous System Lymphoma","volume":"128","author":"Grommes","year":"2016","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","article-title":"Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents","volume":"3","author":"Aldoss","year":"2019","journal-title":"Blood Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-014-2120-2","article-title":"Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia","volume":"94","author":"Tse","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood-2015-07-627323","article-title":"Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia","volume":"126","author":"Halpern","year":"2015","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Dib, R.W., Hachem, R.Y., Chaftari, A.M., Ghaly, F., Jiang, Y., and Raad, I. (2018). Treating invasive aspergillosis in patients with hematologic malignancy: Diagnostic-driven approach versus empiric therapies. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3584-9"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1439-0507.2010.01881.x","article-title":"Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies","volume":"54","author":"Hoenigl","year":"2011","journal-title":"Mycoses"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Fracchiolla, N.S., Scium\u00e8, M., Orofino, N., Guidotti, F., Grancini, A., Cavalca, F., Freyrie, A., Goldaniga, M.C., Consonni, D., and Mattiello, V. (2019). Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216715"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/bjc.2012.147","article-title":"Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: A systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Ethier","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0163-4453(98)80173-4","article-title":"An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome","volume":"37","author":"Denning","year":"1998","journal-title":"J. Infect."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/7\/722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:48:12Z","timestamp":1760140092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/7\/722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":107,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jof8070722"],"URL":"https:\/\/doi.org\/10.3390\/jof8070722","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]}}}